Rocket Lab Corporation (NASDAQ:RKLB) saw its shares retreat 4.8% on Friday, closing at $64.57, as investors weighed the completion of a massive capital raise against lingering regulatory uncertainty surrounding the company's proposed acquisition of Iridium Communications (NASDAQ:IRDM). The pullback erased a significant portion of Thursday's 6.48% advance, with volume reaching 32.17 million shares—about 1.55 times the 10-session average.
The stock's reversal comes on the heels of a $1.944 billion equity offering, which involved the issuance of 29.3 million new shares. The financing, completed on September 15, was a key step in funding the cash portion of the Iridium deal, but it also made the dilution visible to investors. The average gross sale price per share in the offering was calculated at $66.35, meaning Friday's close sits roughly 2.7% below that level.
Regulatory Path Less Advanced Than Hoped
While the financing risk has been removed, the regulatory approval process for the Iridium acquisition remains in its early stages. The Federal Communications Commission (FCC) has only accepted the transfer applications for filing—a procedural step that does not constitute approval. Market chatter had suggested a smoother path, but the FCC's formal comment period is still open, with comments due by October 15 and final replies by November 9.
Iridium shareholders are scheduled to vote on the deal on September 24 at 08:30 EDT. This vote is a critical milestone, as shareholder approval is required for the transaction to proceed. If Iridium holders reject the deal, or if the FCC imposes conditions that delay closing, the thesis for Rocket Lab's acquisition could be significantly undermined.
Broader Space Selloff
Rocket Lab was not the only space stock to decline on Friday. AST SpaceMobile (NASDAQ:ASTS) fell 6.68%, while Intuitive Machines (NASDAQ:LUNR) dropped 5.88%. The synchronized decline suggests that sector-wide factors, such as profit-taking or risk-off sentiment, played a role in Friday's move, rather than company-specific news alone. However, Rocket Lab's financing overhang remains a unique overhang.
Financing Structure and Balance Sheet
The company replaced its previous bridge loan commitment with a combination of equity and term debt. The $3.6 billion senior bridge commitment was terminated on September 15, eliminating the need for temporary acquisition debt and its associated refinancing risk. In its place, Rocket Lab now has a $1.775 billion Iridium term loan, which is subject to a change-of-control consent and guaranteed by the parent company at closing.
As of June 30, Rocket Lab reported cash and current securities of $2.302 billion. The ATM equity raise added $1.944 billion in gross proceeds, bringing the total liquidity to more than $4 billion before transaction payments. This war chest provides ample funding for the cash consideration, but it also underscores the scale of the deal relative to Rocket Lab's operations—the second-quarter revenue was just $234 million, while the ATM raised more than eight times that amount.
Iridium's Cash-Generating Appeal
Iridium, on the other hand, brings a steady stream of service revenue. The company reported $225.2 million in second-quarter revenue, with service revenue accounting for 72% of that total. Operational EBITDA reached $119.1 million, providing a solid cash flow base. However, Iridium also carries $1.8 billion in gross term debt, and its cash balance was only $184.2 million as of June 30, adding leverage and integration risks to the combined entity.
Analyst Targets Point to Upside—But Vary Widely
Despite Friday's decline, analysts remain broadly bullish on Rocket Lab. Raymond James initiated coverage with an Outperform rating and an $80 price target, implying 23.9% upside from Friday's close. Berenberg set a Buy rating with an $83 target, while Bank of America cut its target from $115 to $110 but maintained a Buy. Cantor Fitzgerald raised its target from $96 to $122, suggesting 88.9% upside. These targets reflect confidence in Rocket Lab's launch backlog and the potential for Iridium's recurring revenue to bolster the business model.
However, the wide range of targets indicates significant uncertainty about the deal's success and the pace of integration. The strongest bull case is that Rocket Lab has now funded the cash portion without retaining costly bridge debt, removing a major financial overhang. But the bear case hinges on regulatory delays, shareholder rejection, integration costs, or further equity dilution before Neutron, the company's next-generation rocket, begins generating meaningful revenue.
As the September 24 shareholder vote and October 15 FCC comment deadline approach, investors will be watching closely to see whether Friday's reversal was a temporary blip or the beginning of a more difficult closing process.
